196,081 research outputs found
Offenders with mental health problems and problematic substance use : treatment interventions and crime relapse
No full textBackground: The relationships between problematic substance use, mental health problems and criminal behavior have been firmly established in research. Offenders with mental health problems and concurrent problematic substance use have high risk of reoffending and may display low rates of treatment retention. The overall aim of this thesis was to explore treatment needs, treatment participation and crime relapse among Swedish offenders with mental health problems and problematic substance use. Methods: The studies composing this thesis were part of the larger ongoing prospective follow-up project: Mental Disorder, Substance Abuse and Crime (MSAC) (n = 207) including offenders with mental health problems and problematic substance use in Stockholm County. Data from the baseline assessment and follow-up assessments of the MSAC-project were analyzed, as well as data gathered from Swedish registers and semi structured in-depth interviews. The participants were followed for approximately three years. Both quantitative and qualitative methodological approaches were used.Results: The following main findings emerged: (1) Participation in planned substance abuse outpatient visits was associated with a significantly reduced risk of criminal recidivism in the study population. (2) Higher scores of the Antisocial Psychopathy Checklist-Revised (PCL-R) facet and membership of a subgroup described as “Triply troubled with medical problems” were associated with an increased risk of criminal recidivism. (3) The Affective PCL-R facet was negatively related with participation in planned outpatient substance abuse visits and dry housing residence. (4) Among participants with various degrees of psychopathic personality traits, there were more similarities than differences in perceptions of substance abuse treatment. However, participants with a low degree of such traits stated that control requirements in treatment were rather manageable; whereas those with a high degree of psychopathic personality traits expressed that those requirements were difficult to fulfill. (5) All participants of the four previously defined subgroups/clusters of the study population showed improvements with regard to problem severity over the course of time, but the improvements were cluster-specific rather than sample specific. Cluster membership could also predict treatment participation and quality of life. (6) The Alcohol Use Disorders Identification Test (AUDIT) and the Drug Use Disorders Identification Test (DUDIT) showed reliability and concurrent validity in screening for substance dependence of alcohol and illicit drugs, as well as problem severity with regard to alcohol, drugs and illegal areas.Conclusions: Among offenders with mental health problems and problematic substance use, participation in planned outpatient substance abuse interventions should be considered important from a clinical risk management perspective, and be encouraged. Some personality traits as well as subgroup membership (based on specific problem profiles) could be considered in order to individualize treatment planning and improve outcomes. In order to identify problematic substance use, the AUDIT and the DUDIT questionnaires could be used.List of scientific papersI. Durbeej, N., Berman, A.H., Gumpert, C.H., Palmstierna, T., Kristiansson. M., & Alm, C. (2010). Validation of the Alcohol Use Disorders Identification Test and the Drug Use Disorders Identification Test in a Swedish sample of suspected offenders with signs of mental health problems: Results from the Mental disorder, Substance Abuse and Crime study. Journal of Substance Abuse Treatment, 39, 364–377. https://doi.org/10.1016/j.jsat.2010.07.007 II. Durbeej, N., Alm, C., & Gumpert, C.H. (2014). Perceptions of treatment among offenders with mental health problems and problematic substance use - The possible relevance of psychopathic personality traits. Open Journal of Psychiatry, 4, 79–90. https://doi.org/10.4236/ojpsych.2014.41012III. Durbeej, N., Palmstierna, T., Berman, A.H., Kristiansson, M., & Gumpert, C.H. (2014). Offenders with mental health problems and problematic substance use: Affective psychopathic personality traits as potential barriers to participation in substance abuse interventions. Journal of Substance Abuse Treatment, 46, 574–583. https://doi.org/10.1016/j.jsat.2014.01.002 IV. Alm, C., Eriksson, Å., Durbeej, N., Palmstierna, T., Berman, A.H., Kristiansson, M., & Gumpert, C.H. (2014). Classification of offenders with mental health problems and problematic substance use using the Addiction Severity Index version 6: analysis of three year follow-up data and predictive validity. Mental Health and Substance use. https://doi.org/10.1080/17523281.2014.891640V. Durbeej, N., Palmstierna, T., Rosendahl, I., Berman, A.H., Kristiansson, M., & Gumpert, C.H. Participation in substance abuse outpatient visits and crime relapse among offenders with mental health problems and problematic substance use: Findings from the Mental Disorder, Substance Abuse, and Crime study. [Manuscript]</p
Dr. Duane M. Jackson, Morehouse College, July 2011
No full textThis video is a conversation with Dr. Duane M. Jackson. Dr. Jackson talks about his paper, "Recall and the Serial Position Effect: The Role of Primacy and Recency on Accounting Students' Performance." Jackie Daniel, AUC Woodruff Library, is the interviewer
"Reflections on the subject of Emigration from Europe with a view to Settlement in the United States" By M. Carey.
No full text"Reflections on the subject of Emigration from Europe with a view to Settlement in the United States: containing bried sketches of the moral and political character of those states.
By M. Carey, member of the American philosophical, and of the American Antiquarian Society, and author of The Olive Branch, Cindiciae Hibernicae, essays on banking, on political economy, and on internal improvement.
To which are now added the English editor's comments on the subject; together with Important Advice to Emigrants, and Cautions Against Impositions Practiced in the Outports
Distinct alpha7A-beta1 and alpha7B-beta1 integrin expression patterns during mouse development: alpha7A is restricted to skeletal muscle but alpha7B is expressed in striated muscle, vasculature, and nervous system.
No full textDispelling the Myths Behind First-author Citation Counts
No full textWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
Dr. Glendon Swarthout
No full textHosted by Roger M. Busfield, MSU Assistant Professor of Speech and Theater, Meet the Author is designed to introduce a general audience to a contemporary author and their work through in-depth interviews. This episode features a conversation between Dr. Glendon Swarthout, prolific author and English professor at MSU, and assistant professors Sam S. Baskett and Theodore B. Strandness
Quantitative Proteomic Analysis Reveals Metabolic Alterations, Calcium Dysregulation, And Increased Expression Of Extracellular Matrix Proteins In Laminin α2 Chain-deficient Muscle
No full textCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Congenital muscular dystrophy with laminin α2 chain deficiency (MDC1A) is one of the most severe forms of muscular disease and is characterized by severe muscle weakness and delayed motor milestones. The genetic basis of MDC1A is well known, yet the secondary mechanisms ultimately leading to muscle degeneration and subsequent connective tissue infiltration are not fully understood. In order to obtain new insights into the molecular mechanisms underlying MDC1A, we performed a comparative proteomic analysis of affected muscles (diaphragm and gastrocnemius) from laminin α2 chain-deficient dy3K/dy3K mice, using multidimensional protein identification technology combined with tandem mass tags. Out of the approximately 700 identified proteins, 113 and 101 proteins, respectively, were differentially expressed in the diseased gastrocnemius and diaphragm muscles compared with normal muscles. A large portion of these proteins are involved in different metabolic processes, bind calcium, or are expressed in the extracellular matrix. Our findings suggest that metabolic alterations and calcium dysregulation could be novel mechanisms that underlie MDC1A and might be targets that should be explored for therapy. Also, detailed knowledge of the composition of fibrotic tissue, rich in extracellular matrix proteins, in laminin α2 chain-deficient muscle might help in the design of future anti-fibrotic treatments. All MS data have been deposited in the ProteomeXchange with identifier PXD000978 (http://proteomecentral.proteomexchange. org/dataset/PXD000978).131130013013Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; 2014-10-6; CAPES; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; KAW2007.0118; Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Allamand, V., Guicheney, P., Merosin-deficient muscular dystrophy, autosomal recessive (mdc1a, mim#156225, lama2 gene coding for -2 chain of laminin) (2002) Eur. J. Hum. Genet., 10, pp. 91-94Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., Tomé, F.M.S., Guicheney, P., Mutations in the laminin -2 chain gene (lama2) cause merosin-deficient muscular dystrophy (1995) Nat. Genet., 11, pp. 216-218Voit, T., Tomé, F.S., The congenital muscular dystrophies (2004) Myology, 2, pp. 1203-1238. , (Angel, A., and Franzini-Armstrong, C., eds McGraw-Hill, New YorkIbraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W., Campbell, K.P., Primary structure of dystrophin-Associated glycoproteins linking dystrophin to the extracellular matrix (1992) Nature, 355, pp. 696-702Talts, J.F., Andac, Z., Gohring, W., Brancaccio, A., Timpl, R., Binding of the g domains of laminin -1 and -2 chains and perlecan to heparin, sulfatides, -dystroglycan and several extracellular matrix proteins (1999) EMBO J., 18, pp. 863-870Von Der Mark, H., Williams, I., Wendler, O., Sorokin, L., Von Der Mark, K., Pöschl, E., Alternative splice variants of -7-1 integrin selectively recognize different laminin isoforms (2002) J. Biol. Chem., 277, pp. 6012-6016Gawlik, K.I., Durbeej, M., Skeletal muscle laminin and mdc1a: Pathogenesis and treatment strategies (2011) Skelet. Muscle, 1, p. 9Han, R., Kanagawa, M., Yoshida-Moriguchi, T., Rader, E.P., Ng, R.A., Michele, D.E., Muirhead, D.E., Campbell, K.P., Basal lamina strengthens cell membrane integrity via the laminin g domain-binding motif of -dystroglycan (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 12573-12579Vachon, P.H., Xu, H., Liu, L., Loechel, F., Hayashi, Y., Arahata, K., Reed, J.C., Engvall, E., Integrins (-7-1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy (1997) J. Clin. Invest., 10, pp. 1870-1881Mayer, U., Integrins: Redundant or important players in skeletal muscle and beyond (2003) J. Biol. Chem., 279, pp. 14587-14590Gawlik, K.I., Mayer, U., Blomberg, K., Sonnenberg, A., Ekblom, P., Durbeej, M., Laminin -1 chain mediated reduction of laminin -2 chain deficient muscular dystrophy involves integrin -7-1 and dystroglycan (2006) FEBS Lett., 580, pp. 1759-1765Moll, J., Barzaghi, P., Lin, S., Bezakova, G., Lochmuller, H., Engvall, E., Muller, U., Ruegg, M.A., An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy (2001) Nature, 413, pp. 302-307Doran, P., Martin, G., Dowling, P., Jockusch, H., Ohlendieck, K., Proteome analysis of the dystrophin-deficient mdx diaphragm reveals a drastic increase in the heat shock protein cvhsp (2006) Proteomics, 6, pp. 4610-4621Gardan-Salmon, D., Dixon, J.M., Lonergan, S.M., Selsby, J.T., Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice (2011) Eur. J. Appl. Physiol., 111, pp. 2763-2773Carberry, S., Zweyer, M., Swandulla, D., Ohlendieck, K., Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of duchenne muscular dystrophy (2012) Int. J. Mol. Med., 30, pp. 229-234Ge, Y., Molloy, M.P., Chamberlain, J.S., Andrews, P.C., Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity (2003) Proteomics, 3, pp. 1895-1903Guevel, L., Lavoie, J.R., Perez-Iratxeta, C., Rouger, K., Dubreil, L., Feron, M., Talon, S., Megeney, L.A., Quantitative proteomic analysis of dystrophic dog muscle (2010) J. Proteome Res., 10, pp. 2465-2449Matsumura, C.Y., Menezes De Oliveira, B., Durbeej, M., Marques, M.J., Isobaric tagging-based quantification for proteomic analysis: A comparative study of spared and affected muscles from mdx mice at the early phase of dystrophy (2013) PLoS One, 8, p. e65831Rayavarapu, S., Coley, W., Cakir, E., Jahnke, V., Takeda, S., Aoki, Y., Grodish-Dressman, H., Nagaraju, K., Identification of disease specific pathways using in vivo silac proteomics in dystrophin deficient mdx mouse (2013) Mol. Cell. Proteomics, 12, pp. 1061-1073Lewis, C., Carverry, S., Ohlendieck, K., Proteomic profiling of x-linked muscular dystrophy (2009) J. Muscle Res. Cell. Motil., 30, pp. 267-279De La Torre, C., Illa, I., Faulkner, G., Soria, L., Robles-Cedeno, R., Pereles-Dominguez-Perles, R., De Luna, N., Gallardo, E., Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients (2009) Proteomics Clin. Appl., 3, pp. 486-497De Morrée, A., Hensbergen, P.J., Van Haagen, H.H., Dragan, I., Deelder, A.M., T'Hoen, P.A., Frants, R., Van Den Maarel, S.M., Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity (2010) PLoS One, 5, p. e13854Washburn, M., Wolters, D., Yates, J., III, Large scale analysis of the yeast proteome by multidimensional protein identification technology (2001) Nat. Biotechnol., 19, pp. 242-247Thompson, A., Schäfer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., Neumann, T., Hamon, C., Tandem mass tags: A novel quantification strategy for comparative analysis of complex protein mixtures by ms/ms (2003) Anal. Chem., 75, pp. 1895-1904Carmignac, V., Quere, R., Durbeej, M., Proteasome inhibition improves the muscle of laminin -2 chain-deficient mice (2011) Hum. Mol. Genet., 20, pp. 541-552Vizcaíno, J.A., Deutsch, E.W., Wang, R., Csordas, A., Reisinger, F., Ríos, D., Dianes, J.A., Hermjakob, H., Proteome-xchange provides globally co-ordinated proteomics data submission and dissemination (2014) Nat. Biotechnol., 32, pp. 223-226Karp, N.A., McCormick, P.S., Russell, M.R., Lilley, K.S., Experimental and statistical considerations to avoid false conclusions in proteomics studies using differential in-gel electrophoresis (2007) Mol. Cell. Proteomics, 6, pp. 1354-1364Storey, J.D., Tibshirani, R., Statistical significance for genome wide studies (2003) Proc. Natl. Acad. Sci. U.S.A., 100, pp. 9440-9445Levin, Y., The role of statistical power analysis in quantitative proteomics (2011) Proteomics, 11, pp. 2565-2567Gawlik, K., Miyagoe-Suzuki, Y., Ekblom, P., Takeda, S., Durbeej, M., Laminin -1 chain reduces muscular dystrophy in laminin -2 chain deficient mice (2004) Hum. Mol. Genet., 13, pp. 1775-1784Kline, K.G., Wu, C.C., Mudpit analysis: Application to human heart tissue (2009) Methods Mol. Biol., 528, pp. 281-293Martins De Souza, D., Oliveira, B.M., Castro-Dias, E., Winck, F.V., Horiuchi, R.S., Baldasso, P.A., Caetano, H.T., Novello, J.C., The untiring search for the most complete proteome representation: Reviewing the methods (2008) Brief Funct. Genomic. Proteomic., 7, pp. 312-321Miyagoe, Y., Hanaoka, K., Nonaka, I., Hayasaka, M., Nabeshima, Y., Arahata, K., Nabeshima, Y., Takeda, S., Laminin -2 chain-null mutant mice by targeted disruption of the lama2 gene: A new model of merosin (laminin 2)-deficient congenital muscular dystrophy (1997) FEBS Lett., 415, pp. 33-39Häger, M., Bigotti, M.G., Meszaros, R., Carmignac, V., Holmberg, J., Allamand, V., Åkerlund, M., Durbeej, M., Cib2 binds integrin -7b-1d and is reduced in laminin -2 chain-deficient muscular dystrophy (2008) J. Biol. Chem., 283, pp. 24760-247695Deconinck, N., Dan, B., Pathophysiology of duchenne muscular dystrophy: Current hypotheses (2007) Pediatr. Neurol., 26, pp. 1-7Vandebrouck, C., Martin, D., Colson-Van Schoor, M., Debaix, H., Gailly, P., Involvement of trpc in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers (2002) J. Cell Biol., 158, pp. 1089-1096Millay, D.P., Sargent, M.A., Osinska, H., Baines, C.P., Barton, E.R., Vuagniaux, G., Sweeney, H.L., Molkentin, J.D., Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy (2008) Nat. Med., 14, pp. 442-447Millay, D.P., Goonasekera, S.A., Sargent, M.A., Maillet, M., Aronow, B.J., Molkentin, J.D., Calcium influx is sufficient to induce muscular dystrophy through a trpc-dependent mechanism (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 19023-19028Culligan, K.G., Ohlendieck, K., Abnormal calcium handling in muscular dystrophy (2002) Basic Appl. Myol., 12, pp. 147-157Straub, V., Rafael, J.A., Chamberlain, J.S., Campbell, K.P., Animal models for muscular dystrophy show different patterns of sarcolemmal disruption (1997) J. Cell Biol., 139, pp. 375-385Gawlik, K.I., Åkerlund, M., Carmignac, V., Elamaa, H., Durbeej, M., Distinct roles for laminin globular domains in laminin -1 chain mediated rescue of murine laminin -2 chain deficiency (2010) PLoS One, 5, p. e11549Rescher, U., Gereke, V., Annexins-unique membrane binding proteins with diverse functions (2004) J. Cell Sci., 117, pp. 2631-2639Probst-Cousinm, S., Berghoff, C., Neundörfer, B., Heuss, D., Annexin expression in inflammatory myopathies (2004) Muscle Nerve, 30, pp. 102-110Jeudi, S., Wardrop, K.E., Alessi, A., Dominov, J.A., Bcl-2 inhibits the innate immune response during early pathogenesis of murine congenital muscular dystrophy (2011) PLoS One, 6, p. e22369Taniguchi, M., Kurahashi, H., Noguchi, S., Sese, J., Okinaga, T., Tsukahara, T., Guicheney, P., Toda, T., Expression profiling from fukuyama-type congenital muscular dystrophy and laminin-2 deficient congenital muscular dystrophyIs congenital muscular dystrophy a primary fibrotic disease? (2006) Biochem. Biophys. Res. Commun., 342, pp. 489-502Kuang, W., Xu, H., Vachon, P.H., Engvall, E., Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models (1998) J. Clin. Invest., 102, pp. 844-852Meinen, S., Barzaghi, P., Lin, S., Lochmuller, H., Rüegg, M.A., Linker molecules between laminins and dystroglycan ameliorate laminin-2-deficient muscular dystrophy at all disease stages (2007) J. Cell Biol., 176, pp. 979-993Doe, J.A., Wuebbles, R.D., Allred, E.T., Rooney, J.E., Elorza, M., Burkin, D.J., Transgenic overexpression of the -7 integrin reduces muscle pathology and improves viability in the dy(w) mouse model of merosin-deficient congenital muscular dystrophy type 1a (2011) J. Cell Sci., 124, pp. 2287-2297Girgenrath, M., Dominov, J.A., Kostek, C.A., Miller, J.B., Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy (2004) J. Clin. Invest., 114, pp. 1635-1639Erb, M., Meinen, S., Barzaghi, P., Sumanovski, L.T., Courdier-Fruh, I., Rüegg, M.A., Meier, T., Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-2 deficiency (2009) J. Pharmacol. Exp. Ther., 331, pp. 787-795Kumar, A., Yamauchi, J., Girgenrath, T., Girgenrath, M., Musclespecific expression of insulin-like growth factor 1 improves outcome in lama2dy-w mice, a model for congenital muscular dystrophy type 1a (2011) Hum. Mol. Genet., 20, pp. 2333-2343Carmignac, V., Svensson, M., Körner, Z., Elowsson, L., Matsumura, C., Gawlik, K., Allamand, V., Durbeej, M., Autophagy is increased in laminin -2 chain-deficient muscle and inhibition improves muscle morphology in a mouse model of mdc1a (2011) Hum. Mol. Genet., 20, pp. 4891-4902Rooney, J.E., Knapp, J.R., Hodges, B.L., Wuebbles, R.D., Burkin, D.J., Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy (2011) Am. J. Pathol., 180, pp. 1593-1602Elbaz, M., Yanay, N., Aga-Mizrachi, S., Brunschwig, Z., Kassis, I., Ettinger, K., Barak, V., Nevo, Y., Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy2j/dy2j mouse (2012) Ann. Neurol., 71, pp. 699-708Meinen, S., Lin, S., Rüegg, M.A., Angiotensin ii type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-2-deficient congenital muscular dystrophy (mdc1a) (2012) Skelet. Muscle, 2, p. 18Turk, R., Sterrenburg, E., Van Der Wees, C.G., De Meijer, E.J., De Menezes, R.X., Groh, S., Campbell, K.P., Hoen, T.P.A., Common pathological mechanisms in mouse models for muscular dystrophies (2006) FASEB J., 20, pp. 127-129Chen, Y.W., Zhao, P., Borup, R., Hoffman, E.P., Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology (2000) J. Cell Biol., 151, pp. 1321-1336Chinet, A.E., Even, P.C., Decrouy, A., Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal muscles (1994) Experientia, 59, pp. 602-605Even, P.C., Decrouy, A., Chinet, A., Defective regulation of energy metabolism in the mdx-mouse skeletal muscles (1994) Biochem. J., 304, pp. 649-654Groh, S., Zong, H., Goddeeris, M.M., Lebakken, C.S., Venzke, D., Pessin, J.E., Campbell, K.P., Sarcoglycan complex: Implications for metabolic defects in muscular dystrophies (2009) J. Biol. Chem., 284, pp. 19178-19182Onopiuk, M., Brutkowski, W., Wierzbicka, K., Wojciechowska, S., Szczepanowska, J., Fronk, J., Lochmuller, H., Zablocki, K., (2009) Biochem. Biophys. Res. Commun., 386, pp. 463-466Le Borgne, F., Guyot, S., Logerot, M., Beney, L., Gervais, P., Demarquoy, J., Exploration of lipid metabolism in relation with plasma membrane properties of duchenne muscular dystrophy cells: Influence of l-carnitine (2012) PLoS One, 7, p. e49346Matsumura, C.Y., Pertille, A., Albuquerge, T.C., Santo Neto, H., Marques, M.J., Diltiazem and verapamil protect dystrophin-deficient muscle fibers of mdx mice from degeneration: A potential role in calcium buffering and sarcolemmal stability (2009) Muscle Nerve, 39, pp. 167-176Jørgensen, L.H., Blain, A., Greally, E., Lavala, S.H., Blamire, A.M., Davison, B.J., Brinkmeier, H., Lochmüller, H., Long-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscle (2011) Am. J. Pathol., 178, pp. 273-283Goonasekera, S.A., Lam, C.K., Millay, D.P., Sargent, M.A., Hajjar, R.J., Kranias, E.G., Molkentin, J.D., Mitigation of muscular dystrophy in mice by serca overexpression in skeletal muscle (2011) J. Clin. Invest., 121, pp. 1044-1052Horiuchi, K., Amizuka, N., Takeshita, S., Takamatsu, H., Katsuura, M., Ozawa, H., Toyama, Y., Kudo, A., Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor (1999) J. Bone Miner. Res., 14, pp. 1239-1249Lorts, A., Schwanekamp, J.A., Baudino, T.A., McNally, E.M., Molkentin, J.D., Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor- pathway (2012) Proc. Natl. Acad. Sci. U.S.A., 109, pp. 10978-10983Ting, L., Rad, R., Gygi, S.P., Haas, W., Ms3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics (2011) Nat. Methods, 8, pp. 937-940Christoforou, A., Lilley, K.S., Taming the isobaric tagging elephant in the rooms in quantitative proteomics (2011) Nat. Methods, 8, pp. 911-91
Simulation of thermal plant optimization and hydraulic aspects of thermal distribution loops for large campuses
No full textFollowing an introduction, the author describes Texas A&M University and its utilities system. After that, the author presents how to construct simulation models for chilled water and heating hot water distribution systems. The simulation model was used in a $2.3 million Ross Street chilled water pipe replacement project at Texas A&M University. A second project conducted at the University of Texas at San Antonio was used as an example to demonstrate how to identify and design an optimal distribution system by using a simulation model. The author found that the minor losses of these closed loop thermal distribution systems are significantly higher than potable water distribution systems. In the second part of the report, the author presents the latest development of software called the Plant Optimization Program, which can simulate cogeneration plant operation, estimate its operation cost and provide optimized operation suggestions. The author also developed detailed simulation models for a gas turbine and heat recovery steam generator and identified significant potential savings. Finally, the author also used a steam turbine as an example to present a multi-regression method on constructing simulation models by using basic statistics and optimization algorithms. This report presents a survey of the author??s working experience at the Energy Systems Laboratory (ESL) at Texas A&M University during the period of January 2002 through March 2004. The purpose of the above work was to allow the author to become familiar with the practice of engineering. The result is that the author knows how to complete a project from start to finish and understands how both technical and nontechnical aspects of a project need to be considered in order to ensure a quality deliverable and bring a project to successful completion. This report concludes that the objectives of the internship were successfully accomplished and that the requirements for the degree of Degree of Engineering have been satisfied
Intern experience at CH���M Hill, Inc.: an internship report
No full textIncludes author's vita"Submitted to the College of Engineering of Texas A&M University in partial
fulfillment of the requirement for the degree of Doctor of Engineering."Includes bibliographical referencesA review of the author's internship experience with CH���M HILL, Inc.
during the period September 1975 through May 1976 is presented. During this nine month
internship the author worked as an Engineer II in the Industrial Processes discipline of this
large consulting engineering firm... The author's prime responsibility was as one of three
lead design engineers on the design of a large wastewater treatment facility for a pulp mill
in Hoquiam, Washington owned by ITT Rayonier Inc. The work generally consisted of the design
of individual treatment units and associated piping and pumping. The purpose of the project
was to provide wastewater treatment capabilities that would satisfy the effluent limitations
(standards) imposed upon the mill by the State of Washington Department of Ecology and the
U.S. Environmental Protection Agency. The author's assignment also entailed necessary
interaction with the project manager and other CH���M HILL design engineers and support staff
members, the client's representatives, and representatives of two other consulting engineering
firms working on the project. Thus, the internship position at CH���M HILL provided considerable
experience coordinating the author's work with the work of other engineers, guiding the design
and administrative efforts of a support staff, and interacting regularly with the client and
other consulting firms. This broad exposure to a variety of engineering and organizational
problems provided a valuable educational experience
Transition to turbulence in a qblique shock-wave/boundary-layer interaction at M=15
No full textDirect numerical simulations are carried out for different forcing techniques to trigger transition during the interaction between an oblique shock-wave and a laminar boundary-layer at M = 1.5. Three forcing methods are used: a) forcing of oblique unstable modes, whose shape and behaviour are determined by the local linear stability theory, b) broadband free-stream acoustic disturbances, and c) a cold plasma flow control device. While the oblique-mode breakdown is dominant for low-amplitude forcing, long streaky structures drive the transition process in a high-amplitude disturbance environment. LES are also performed on the experimental setup by the Institute of Theoretical and Applied Mechanics (ITAM) from Novosibirsk State University with cold plasma actuation. As well as the disturbance type, the effect of Reynolds number and forcing amplitude will be investigated
- …
